The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2023

Filed:

Aug. 14, 2017
Applicant:

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Tinna Bjoerk Aradottir, Copenhagen, DK;

Henrik Bengtsson, Taastrup, DK;

Pete Brockmeier, Copenhagen, DK;

Jonas Kildegaard Pedersen, Vaerloese, DK;

Assignee:

Novo Nordisk A/S, Bagsvaerd, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 20/17 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); G16H 50/30 (2018.01); G16H 20/60 (2018.01); A61K 38/28 (2006.01); A61M 5/142 (2006.01); G16H 10/60 (2018.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01);
U.S. Cl.
CPC ...
G16H 20/17 (2018.01); A61K 38/28 (2013.01); A61M 5/14244 (2013.01); G16H 20/60 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); A61B 5/14532 (2013.01); A61M 5/1723 (2013.01); A61M 2230/201 (2013.01); G16H 10/60 (2018.01);
Abstract

Systems and methods are provided for optimizing short acting insulin medicament dosage timing relative to a meal event for a subject. Glucose measurements of the subject over a time course and the timing of the measurements are obtained. Meal events in the time course and information regarding when dosages were injected into the subject relative to the meal events is obtained. Bins, each for a different time range for when a dosage is injected relative to a meal event, are constructed. Each bin is assigned glucose measurements in one or more periods within the time course in which the subject injected the dosage within the time range associated with the bin. A glycaemic risk measure is determined for each bin with the assigned measurements and used to identify an optimal relative time range for the subject. This is communicated to a health care practitioner or to the subject.


Find Patent Forward Citations

Loading…